{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:09:01Z","timestamp":1793351341967,"version":"4.5.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Spanish Ministry of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Lipid profiles appear to be altered in SLE patients due to disease activity and inflammation. Cholesterol efflux capacity (CEC) is the ability of high-density lipoprotein cholesterol to accept cholesterol from macrophages. CEC has been linked to cardiovascular events in the general population and is impaired in SLE patients. The aim of this study was to establish whether CEC is related to subclinical carotid atherosclerosis in SLE patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The present report is of a cross-sectional study that encompassed 418 individuals: 195 SLE patients and 223 controls. CEC, using an in vitro assay, and lipoprotein serum concentrations were assessed in patients and controls. Carotid intima-media thickness and carotid plaques were evaluated in SLE patients. A multivariable analysis was performed to study the relationship of CEC to SLE-related data, lipid profile and subclinical carotid atherosclerosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>CEC was downregulated in SLE patients [8.1\u2009\u2009(4.2) % vs 16.9 (10.4) %, P = 0.004). This occurred independently of traditional cardiovascular risk factors, statin use or other variations in the lipid profile related to the disease. Traditional cardiovascular risk factors, both in patients and controls, and SLE-related data such as activity, severity or damage were not associated with CEC. After multivariable regression analysis including lipid profile\u2013related molecules, CEC was inversely and independently associated with the presence of carotid plaques in SLE patients [odds ratio 0.87 (95% CI: 0.78, 0.97), P = 0.014].<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>CEC is impaired in SLE patients independently of other inflammation-related lipid profile modifications that occur during the disease. CEC is associated with carotid plaques in SLE patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa038","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T04:28:44Z","timestamp":1579235324000},"page":"2847-2856","source":"Crossref","is-referenced-by-count":41,"title":["Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis"],"prefix":"10.1093","volume":"59","author":[{"given":"Hiurma","family":"S\u00e1nchez-P\u00e9rez","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Hospital Universitario de Canarias, Tenerife"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Quevedo-Abeledo","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Doctor Negr\u00edn, Las Palmas de Gran Canaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"de Armas-Rillo","sequence":"additional","affiliation":[{"name":"Universidad Europea de Canarias, Tenerife"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00cd\u00f1igo\u00a0","family":"Rua--Figueroa","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Doctor Negr\u00edn, Las Palmas de Gran Canaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Tejera-Segura","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Armas-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Microbiology, Cell Biology and Genetics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9\u00a0David\u00a0","family":"Machado","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Universidad de La Laguna"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A","family":"Garc\u00eda-Dopico","sequence":"additional","affiliation":[{"name":"Division of Central Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Jimenez-Sosa","sequence":"additional","affiliation":[{"name":"Research Unit, Hospital Universitario de Canarias, Tenerife"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos\u00a0","family":"Rodr\u00edguez--Lozano","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Doctor Negr\u00edn, Las Palmas de Gran Canaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"D\u00edaz-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Universitario de Canarias, Tenerife"},{"name":"Department of Internal Medicine, Faculty of Medicine, Universidad de La Laguna, La Laguna"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A","family":"Gonz\u00e1lez-Gay","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Universitario Marqu\u00e9s de Valdecilla, Universidad de Cantabria"},{"name":"Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL, Santander, Spain"},{"name":"Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0197-5267","authenticated-orcid":false,"given":"Iv\u00e1n","family":"Ferraz-Amaro","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Universitario de Canarias, Tenerife"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,17]]},"reference":[{"key":"2020092423550703100_keaa038-B1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semarthrit.2012.12.002","article-title":"The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review","volume":"43","author":"Schoenfeld","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"2020092423550703100_keaa038-B2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/rheumatology\/kep102","article-title":"Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort","volume":"48","author":"Pons-Estel","year":"2009","journal-title":"Rheumatology"},{"key":"2020092423550703100_keaa038-B3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1445-5994.2006.01044.x","article-title":"Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus","volume":"36","author":"Lee","year":"2006","journal-title":"Intern Med J"},{"key":"2020092423550703100_keaa038-B4","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"key":"2020092423550703100_keaa038-B5","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.semarthrit.2015.10.010","article-title":"Dyslipidemia in systemic lupus erythematosus: just another comorbidity?","volume":"45","author":"Tselios","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2020092423550703100_keaa038-B6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s12026-016-8892-9","article-title":"Dyslipidemia in systemic lupus erythematosus","volume":"65","author":"Szab\u00f3","year":"2017","journal-title":"Immunol Res"},{"key":"2020092423550703100_keaa038-B7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11926-009-0036-y","article-title":"Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosus","volume":"11","author":"Reiss","year":"2009","journal-title":"Curr Rheumatol Rep"},{"key":"2020092423550703100_keaa038-B8","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"2020092423550703100_keaa038-B9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N Engl J Med"},{"key":"2020092423550703100_keaa038-B10","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N Engl J Med"},{"key":"2020092423550703100_keaa038-B11","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2020092423550703100_keaa038-B12","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/annrheumdis-2012-203101","article-title":"Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study","volume":"73","author":"Corrales","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2020092423550703100_keaa038-B13","first-page":"S-99-104","article-title":"Assessing remission in systemic lupus erythematosus","volume":"24 Suppl 43","author":"Mosca","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"2020092423550703100_keaa038-B14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/096120339300200210","article-title":"A simple severity of disease index for systemic lupus erythematosus","volume":"2","author":"Katz","year":"1993","journal-title":"Lupus"},{"key":"2020092423550703100_keaa038-B15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13075-017-1311-3","article-title":"HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis","volume":"19","author":"Tejera-Segura","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2020092423550703100_keaa038-B16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000097034","article-title":"Mannheim carotid intima-media thickness consensus (2004\u20132006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006","volume":"23","author":"Touboul","year":"2007","journal-title":"Cerebrovasc Dis"},{"key":"2020092423550703100_keaa038-B17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/art.23196","article-title":"Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus","volume":"58","author":"Thompson","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2020092423550703100_keaa038-B18","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.amjcard.2013.05.040","article-title":"Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosus","volume":"112","author":"Kao","year":"2013","journal-title":"Am J Cardiol"},{"key":"2020092423550703100_keaa038-B19","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/annrheumdis-2012-202914","article-title":"Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus","volume":"73","author":"Ronda","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2020092423550703100_keaa038-B20","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/art.39675","article-title":"Effect of drug therapy on net cholesterol efflux capacity of high-density lipoprotein-enriched serum in rheumatoid arthritis","volume":"68","author":"Ormseth","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2020092423550703100_keaa038-B21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/rheumatology\/kep366","article-title":"The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review","volume":"49","author":"Westlake","year":"2010","journal-title":"Rheumatology"},{"key":"2020092423550703100_keaa038-B22","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med"},{"key":"2020092423550703100_keaa038-B23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11883-015-0554-1","article-title":"HDL cholesterol efflux capacity: cardiovascular risk factor and potential therapeutic target","volume":"18","author":"Bhatt","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"2020092423550703100_keaa038-B24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/ijerph7010325","article-title":"To match or not to match in epidemiological studies\u2014same outcome but less power","volume":"7","author":"Faresj\u00f6","year":"2010","journal-title":"Int J Environ Res Public Health"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/2847\/33790302\/keaa038.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/2847\/33790302\/keaa038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T03:56:36Z","timestamp":1601006196000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/10\/2847\/5739516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,17]]},"references-count":24,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,2,17]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa038","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,2,17]]}}}